Darby John Patrick, an officer serving as EVP, General Counsel & Secretary, sold Encompass Health common stock at a weighted average price of $125.95 per share (individual trades ranged from $125.94 to $126.04) for total reported proceeds of $1,121,710 and directly owns 75,041 shares following the transaction.

Mark J. Tarr, a director and President & CEO, sold Encompass Health common stock on August 10, 2026, comprising 171,569 shares at a weighted average price of $125.46 and 1,579 shares at a weighted average price of $126.06 for total proceeds of $21,724,095 and directly owns 267,814 shares following the transactions.

Douglas E. Coltharp, an officer serving as EVP & Chief Financial Officer, sold 18,869 shares of Encompass Health common stock on August 10, 2026, at a weighted average price of $125.38 per share (transactions ranged from $125.03 to $125.69) for total sale proceeds of $2,365,795 and directly owns 50,508 shares and indirectly owns 190,860 shares via irrevocable trusts and spouse following the transaction.